Inter- and intracellular heterogeneity of O6-alkylguanine-DNA alkyltransferase expression in human brain tumours: Possible significance in nitrosourea therapy

Carcinogenesis

Volumn 17, Issue 4, 1996, Pages 637-641

  Lee, S M ^a   Reid, H ^b   Elder, R H ^a   Thatcher, N ^a   Margison, G P ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; NITROSOUREA; POLYCLONAL ANTIBODY;

ARTICLE; BRAIN TUMOR; CELL NUCLEUS; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE; XENOGRAFT;

ANTINEOPLASTIC AGENTS, ALKYLATING; ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; CARMUSTINE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; METHYLTRANSFERASES; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;

EID: 0029935385     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.4.637     Document Type: Article

References (45)

1. Walker,M.D. and Hurwitz,B.S. (1970) BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) (NSC-409926) in the treatment of malignant brain tumors. A preliminary report. Cancer Chemother. Rep., 54, 263-271.
2. Wilson,C.B., Boldrey,E.B. and Enot,K.J. (1970) 1,3-Bis(2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors. Cancer Chemorher. Rep., 54, 273-281.
3. Kelly,K., Kirkwood,J.M. and Kapp,D.S. (1984) Glioblastoma multiforme: pathology, natural history and treatment. Cancer Treat. Rev., 11, 1-26.
4. Levin,V.A. (1985) Chemotherapy of primary brain tumors. Neural. Clin., 3, 855-866.
5. Stewart,D.J. (1989) The role of chemotherapy in the treatment of gliomas in adults. Cancer Treatment Rev., 16, 129-160.
6. 6-methyguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas. Cancer Res, 44, 2467-2474.
7. 6-alkylguanine DNA adducts in glioma-derived human cells resistant to the cytotoxic and cytogenetic effects of 1.3-bis(2-chloroethyl)-1-nitrosourea. Carcinogenesis, 7, 879-883.
8. Aida,T. and Bodell,W.J. (1987) Cellular resistance to chloroethyl-nitrosoureas. nitrogen nitrogen, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines. Cancer Res., 47, 1361-1366.
9. 6-alkylguanine-DNA-alkyltransferase activity potentiates cytotoxicity and induction of SCEs in human glioma cells resistant to 1.3-bis(chloroethyl)-1-nitrosourea. Carcinogenesis, 8, 1219-1223.
10. Tokuda,K. and Bodell,W.J. (1988) Cytotoxicity and induction of sister chromatid exchanges in human and rodent tumor cells treated with alkylating chemotherapeutic agents Cancer Res., 48, 3100-3105.
11. 6-Alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts J. Neurosurg., 70, 573-577.
12. 6-benzylguanine and its effect on the sensitivity of a human glioma tumor to 1 -(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea. Cancer Commun., 2, 371-377
13. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res., 51, 3367-3372.
14. - parentage. Proc. Am. Ass. Cancer Res., 32, 355.
15. 6-alkyltransferase (AT) in cancer chemotherapy. Cancer Treat. Rev., 15, 279-292.
16. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50, 6119-6129.
17. Kataoka,H., Hall,J. and Karran,P. (1986) Complementation of sensitivity to alkylating agents in Escherichia coli and Chinese hamster cells by expression of a cloned bacterial bacterial repair gene. EMBO J., 5, 3195-3200.
18. Samson,L., Derfler,B. and Waldstein,E.A. (1986) Suppression of human alkylation-repair defects by Escherichia coli DNA-repair genes. Proc. Natl Acad. Sci. USA, 83, 5607-5610.
19. 6-alkylguanine DNA-alkyltransferase gene are less susceptible to SCE induction and chromosome damage by methylating agents. Carcinogenesis, 7, 2077-2080.
20. Jelinek,J , Kleibl,K., Dexter,T M. and Margison,G.P. (1988) Transfection of munne multi-potent haemopoietic stem cells with an E.coli DNA alkyitransferase gene confers resistance to the toxic effects of alkylating agents. Carcinogenesis, 9, 81-87.
21. 6-methylguanine by normal and transformed human cells. Proc. Am. Ass. Cancer Res., 24, 335-337.
22. Chang,C.H., Horton,J., Schoenfield,D., Salazer,O., Perez-Tamayo,R., Kramer,S., Weinstein,A., Nelson,J.S. and Tsukada,K. (1985) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas Cancer, 51, 997-1007.
23. 6-alkylguanine-DNA-alkyltransferase in situ in ovarian and Hodgkin's tumours. Eur. J. Cancer. 29A, 1306-1312.
24. 6-Alkylguanine-DNA alkyitransferase depletion and regeneration in human peripheral lymphocytes followins dacarbazine and fotemustine. Cancer Res., 51, 619-623.
25. 6-alkylguanine-DNA alkyltransferase in human liver and melanoma. Br. J. Cancer, 66, 355-360.
26. Parsons,P.G., Smellie,S.G., Morrison,L E. and Hayward,I.P. (1982) Properties of human melanoma cells resistant to 5-(3′-3′-dimethyl-I-triazeno)imidazole-4-carboxamide and other methylating agents. Cancer Res., 42, 1454-1461
27. 6-alkylguanine alkyltransferase activity in Chinese hamster V79 cells following selection with chloroethylating agents. Carcinogenesis, 9, 45-49.
28. Kornblith,P.L. and Szypko,P.E (1978) Variations in response of human brain tumors to BCNU in vitro. J. Neurosurg., 48, 580.
29. Rosenblum,M.L., Gerosa,M.A , Wilson,C.B , Barger,G.R., Pertuiset,B.R. de-Tribolet,N. and Dougherty,D.V. (1983) Stem cell studies of human malignant brain tumors. Part 1: development of the stem cell assay and its potential. J. Neurosurg , 58, 170-176.
30. Thomas,D.G.T. et al (1985) Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma. Br. J. Cancer, 51, 525-532.
31. Yung,W.A., Shapiro,J.R. and Shapiro,W.R. (1982) Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res., 42, 992-998.
32. Shapiro,J.R., Pu,P.Y., Mohamed,A.N., Nielsen,S.L , Sundaresan,N. and Shapiro,W.R. (1984) Regional heterogeneity in high grade gliomas. Proc. Am. Ass. Cancer Res., 25, 375.
33. 6-Alkylguanine-DNA alkyltransferase activity in human brain tumors. Carcinogenesis, 5, 121-124.
34. 6-methyguanine-DNA-methytransferase and uracil glycosylase in human organs. Carcinogenesis, 4, 1565-1568.
35. 6-Alkylguanine-DNA alkyltransferase activity in human brain tumors Cancer Lett., 55, 153-158.
36. 6-Methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary. Cancer Res., 51, 4131-4134.
37. 6-alkylguanine DNA alkyltransferase in a cell line sensitive to alkylating agents. Carcinogenesis. 10, 13-1619.
38. - human tumor cells. Cancer Res., 50, 7908-7911.
39. - human tumor cell lines containing the MGMT gene by the polymerase chain reaction technique. Cancer Commun., 2, 13-20.
40. 6-methylguanine-DNA methyltransferase in malignant human glioma cell lines. Carcinogenesis, 12, 1739-1744.
41. 6-methylguanine in DNA. J. Mol. Biol., 213, 739-747.
42. 6-methylguanine-DNA methyltransferase. J. Mol. Biol., 265, 9563-9569.
43. 6-alkylguanine. Proc. Natl Acad. Sci. USA, 87, 686-690.
44. 6-alkylguanine-DNA alkyltransferase activity is not detected in nitrosourea resistant or sensitive human cell lines. Carcinogenesis, 11, 479-483.
45. 6-methylguanine DNA methyltransferase gene. Cancer Commun., 3, 241-253.